[Translation] A single-center, randomized, open-label, two-sequence, two-period, double-crossover, fasting bioequivalence study of budesonide-formoterol inhalation powder in healthy Chinese adult subjects
以海南美乐康药业有限公司提供的布地奈德福莫特罗吸入粉雾剂(商品名:Gibiter Easyhaler®,规格:每支60吸,每吸含布地奈德320μg和富马酸福莫特罗9.0μg,Orion Pharma持证)为受试制剂,以AstraZeneca AB持证的布地奈德福莫特罗吸入粉雾剂(商品名:Symbicort Turbuhaler®,规格:每支60吸,每吸含布地奈德320μg和富马酸福莫特罗9.0μg)为参比制剂,评估空腹状态下两种制剂的生物等效性,并评估两药的安全性
[Translation] The budesonide-formoterol inhalation powder provided by Hainan Meiluokang Pharmaceutical Co., Ltd. (trade name: Gibiter Easyhaler®, specification: 60 inhalations per tube, each containing 320 μg budesonide and 9.0 μg formoterol fumarate, licensed by Orion Pharma) was used as the test preparation, and the budesonide-formoterol inhalation powder licensed by AstraZeneca AB (trade name: Symbicort Turbuhaler®, specification: 60 inhalations per tube, each containing 320 μg budesonide and 9.0 μg formoterol fumarate) was used as the reference preparation to evaluate the bioequivalence of the two preparations in the fasting state, and to evaluate the safety of the two drugs.